Clinical Trials in New York

Showing 9261-9280 of 22,668 trials

Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia

NCT03373201

The aim of this study is to investigate tasimelteon vs. placebo on sleep in healthy individuals after a phase advance in jet lag type insomnia.

Jet Lag Type Insomnia

Vanda Pharmaceuticals320 participantsStarted Oct 2017

Little Rock, Arkansas, United States • Alameda, California, United States • San Diego, California, United States +9 more locations

WITHDRAWNPhase 2< 1 mile

INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

NCT05359692

The purpose of this study is to determine the safety, tolerability, efficacy, PK and pharmacodynamics of INCAGN01876 when given in combination with retifanlimab. The study will consist of 2 parts: a safety lead-in part (Part 1) followed by a dose expansion part (Part 2).

Metastatic Head and Neck Squamous Cell CarcinomaAdvanced MalignanciesRecurrent Head and Neck Squamous Cell Carcinoma

Incyte Biosciences International SàrlStarted Mar 2023

Birmingham, Alabama, United States • La Jolla, California, United States • Palo Alto, California, United States +14 more locations

Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia

INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Find Trials by Condition in New York

Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009)

TKA Melatonin and Sleep Quality

Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy

Clinical Use Cases Assessment of the Gabi System in Young Children With Underlying Medical Conditions (BRIDGE Study)

A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens

Multi-Center Pilot Study of Cutera truSculpt Device

Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)

3-D Reconstruction of CT Scan Images in the Evaluation of Non-Specific Pulmonary Nodules

Cancer Control Following Polypectomy

Addressing Dementia Via Agitation-Centered Evaluation

Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012)

Consolidation Pembrolizumab Following Chemoradiation in Patients With Inoperable/Unresectable Stage III NSCLC

Study of a Novel Laser for Skin Rejuvenation

Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

Anti-HIV Medications for People Recently Infected With HIV

A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor

Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function